Home/Filings/4/0001415889-25-003519
4//SEC Filing

Gupta Rishi 4

Accession 0001415889-25-003519

CIK 0001672619other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 5:36 PM ET

Size

5.6 KB

Accession

0001415889-25-003519

Insider Transaction Report

Form 4
Period: 2025-02-06
Gupta Rishi
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2025-02-06+20,49120,491 total
    Exercise: $22.47Exp: 2035-02-06Common Stock (20,491 underlying)
Footnotes (1)
  • [F1]100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2025 annual meeting of the Issuer's stockholders or (ii) the date of the 2026 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date.

Issuer

Enliven Therapeutics, Inc.

CIK 0001672619

Entity typeother

Related Parties

1
  • filerCIK 0001537370

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:36 PM ET
Size
5.6 KB